tobramycin has been researched along with Liver Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baer, DM; Horner, W; Jones, RN; Mullooly, JP | 1 |
| Hardy, BG; Heller, AS; Schentag, JJ; Wels, PB | 1 |
| Lietman, PS; Moore, RD; Smith, CR | 1 |
1 trial(s) available for tobramycin and Liver Diseases
| Article | Year |
|---|---|
Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Double-Blind Method; Female; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Nafcillin; Tobramycin | 1986 |
2 other study(ies) available for tobramycin and Liver Diseases
| Article | Year |
|---|---|
Protocol for the study of drug interferences in laboratory tests: cefotaxime interference in 24 clinical tests.
Topics: Blood Chemical Analysis; Cefotaxime; False Positive Reactions; Female; Gentamicins; Heart Diseases; Humans; Kidney Diseases; Liver Diseases; Male; Pregnancy; Probability; Tobramycin | 1983 |
Antibiotic penetration in liver infection: a case of tobramycin failure responsive to moxalactam.
Topics: Adult; Athletic Injuries; Bilirubin; Creatinine; Enterobacter; Enterobacteriaceae Infections; Humans; Liver; Liver Diseases; Male; Moxalactam; Time Factors; Tissue Distribution; Tobramycin; Wounds, Nonpenetrating | 1983 |